2010
DOI: 10.1097/jto.0b013e3181dd0ef1
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of Therapy Responses and Prediction of Survival in Malignant Pleural Mesothelioma Through Computer-Aided Volumetric Measurement on Computed Tomography Scans

Abstract: Changes in tumor volume after two cycles of chemotherapy predicted overall survival in patients with malignant pleural mesothelioma. Tumor volume at baseline was shown to be associated with preoperative clinical stage and survival. Computer-aided volumetric measurements may enable more reliable therapeutic response assessment and could provide additional prognostic information.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
51
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 84 publications
(52 citation statements)
references
References 44 publications
1
51
0
Order By: Relevance
“…RECIST defined response rates do not necessarily correlate with outcome and survival [5]. We undertook the present study to evaluate whether a new systematic, imaging interpretation paradigm, QVS, could perform better than conventional RECIST scoring in assessing patient outcomes in metastatic melanoma.…”
Section: Introductionmentioning
confidence: 98%
“…RECIST defined response rates do not necessarily correlate with outcome and survival [5]. We undertook the present study to evaluate whether a new systematic, imaging interpretation paradigm, QVS, could perform better than conventional RECIST scoring in assessing patient outcomes in metastatic melanoma.…”
Section: Introductionmentioning
confidence: 98%
“…Other modalities, such as MRI (24) and 18 F-FDG PET/ CT (22,36,44) have been successfully used to measure tumor volume in MPM ( Table 1). For MRI, tumor segmentation has been performed using a HASTE (halfFourier single-shot fast spin-echo) sequence, but this can be limited by signal inhomogeneity and motion artifacts, with a segmentation time of 10 minutes described per patient (45).…”
Section: Measurement Of Tumor Volume On Mri and Pet/ctmentioning
confidence: 99%
“…They do not account for anisotropic tumor growth which might lead to different assessment of tumor response [4,20,21]. Recent studies support the evidence that volumetric measurements might improve the assessment of tumor growth [22,23]. Still, until today there are no guidelines for assessing tumor growth and therapy response through segmentation and volumetry.…”
mentioning
confidence: 99%